Profile picture

Professor Marija Vavlukis

University Clinic of Cardiology, Skopje (North Macedonia)
Membership: FESC Member ACVC Member
Follow
Biography
Prof. d-r Marija Vavlukis has completed her Ph.D. at the age of 44 years from Ss’ Cyril and Methodius University in Skopje, Medical Faculty, Macedonia. She was a Head of ICCU at the University Clinic of Cardiology, Head of Department for internal medicine. Areas of interest: acute cardiac care conditions, acute and chronic CAD, non-invasive cardiac imaging, and preventive medicine. She is a National Coordinator of The American-Austrian Foundation-Open Medical institute, National coordinator in ACVC for Macedonia, FESC since 2016. She served as a nucleus member of the Working Group for coronary pathophysiology and microcirculation (2018-2024). She has published more than 160 papers in reputed journals, 120 on Web of Science. She participated at national/international congresses, symposiums, workshops, other meetings with plenary or oral presentations on more than 40 occasions. She has been serving as an editorial board member and reviewer in several Journals of repute.
Logo ESC

Contributor content

Pathophysiology of ischaemic heart disease
Session
Pathophysiology of ischaemic heart disease
1 September 2025
Revascularisation in coronary artery disease
Session
Revascularisation in coronary artery disease
31 August 2025
Chronic coronary syndromes: revascularisation - miscellaneous and issues
Session
Chronic coronary syndromes: revascularisation - miscellaneous and issues
30 August 2025
MINOCA in clinical practice and myocardial infarction in middle-aged men
Session
MINOCA in clinical practice and myocardial infarction in middle-aged men
28 August 2023
MINOCA in clinical practice (1)
Session
MINOCA in clinical practice (1)
27 August 2023
Special subgroups of acute coronary syndromes: patients with renal disease, patients without classical modifiable risk factors, patients with low risk for early discharge
Session
Special subgroups of acute coronary syndromes: patients with renal disease, patients without classical modifiable risk factors, patients with low risk for early discharge
25 August 2023

ESC 365 is supported by